These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9671748)

  • 61. Mutations in MLH1 are more frequent than in MSH2 in sporadic colorectal cancers with microsatellite instability.
    Herfarth KK; Kodner IJ; Whelan AJ; Ivanovich JL; Bracamontes JR; Wells SA; Goodfellow PJ
    Genes Chromosomes Cancer; 1997 Jan; 18(1):42-9. PubMed ID: 8993979
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features.
    Schiemann U; Müller-Koch Y; Gross M; Daum J; Lohse P; Baretton G; Muders M; Mussack T; Kopp R; Holinski-Feder E
    Digestion; 2004; 69(3):166-76. PubMed ID: 15118395
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparative analysis of DNA mutations in lacI transgenic mice with age.
    Lee AT; DeSimone C; Cerami A; Bucala R
    FASEB J; 1994 May; 8(8):545-50. PubMed ID: 8181674
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Through a glass, darkly: reflections of mutation from lacI transgenic mice.
    Stuart GR; Glickman BW
    Genetics; 2000 Jul; 155(3):1359-67. PubMed ID: 10880494
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mutant frequencies and mutation spectra of dimethylnitrosamine (DMN) at the lacI and cII loci in the livers of Big Blue transgenic mice.
    Shane BS; Smith-Dunn DL; de Boer JG; Glickman BW; Cunningham ML
    Mutat Res; 2000 Sep; 452(2):197-210. PubMed ID: 11024479
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The mechanisms underlying MMR deficiency in immunodeficiency-related non-Hodgkin lymphomas are different from those in other sporadic microsatellite instable neoplasms.
    Borie C; Colas C; Dartigues P; Lazure T; Rince P; Buhard O; Folliot P; Chalastanis A; Muleris M; Hamelin R; Mercier D; Oliveira C; Seruca R; Chadburn A; Leblond V; Barete S; Gaïdano G; Martin A; Gaulard P; Fléjou JF; Raphael M; Duval A
    Int J Cancer; 2009 Nov; 125(10):2360-6. PubMed ID: 19551857
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cellular determinants of the mutational specificity of 1-nitroso-6-nitropyrene and 1-nitroso-8-nitropyrene in the lacI gene of Escherichia coli.
    Lambert IB; Carroll C; Laycock N; Koziarz J; Lawford I; Duval L; Turner G; Booth R; Douville S; Whiteway J; Nokhbeh MR
    Mutat Res; 2001 Dec; 484(1-2):19-48. PubMed ID: 11733069
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Allelic imbalance at the DNA mismatch repair loci, hMSH2, hMLH1, hPMS1, hPMS2 and hMSH3, in squamous cell carcinoma of the head and neck.
    Nunn J; Nagini S; Risk JM; Prime W; Maloney P; Liloglou T; Jones AS; Rogers SR; Gosney JR; Woolgar J; Field JK
    Oral Oncol; 2003 Feb; 39(2):115-29. PubMed ID: 12509964
    [TBL] [Abstract][Full Text] [Related]  

  • 69. MutS homologs in mammalian cells.
    Fishel R; Wilson T
    Curr Opin Genet Dev; 1997 Feb; 7(1):105-13. PubMed ID: 9024626
    [TBL] [Abstract][Full Text] [Related]  

  • 70. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
    Recio L; Saranko CJ; Steen AM
    Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cell lineage-specific effects associated with multiple deficiencies of tumor susceptibility genes in Msh2(-/-)Rb(+/-) mice.
    Nikitin AY; Liu CY; Flesken-Nikitin A; Chen CF; Chen PL; Lee WH
    Cancer Res; 2002 Sep; 62(18):5134-8. PubMed ID: 12234974
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mouse models for hereditary nonpolyposis colorectal cancer.
    de Wind N; Dekker M; van Rossum A; van der Valk M; te Riele H
    Cancer Res; 1998 Jan; 58(2):248-55. PubMed ID: 9443401
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Role for mismatch repair proteins Msh2, Mlh1, and Pms2 in immunoglobulin class switching shown by sequence analysis of recombination junctions.
    Schrader CE; Vardo J; Stavnezer J
    J Exp Med; 2002 Feb; 195(3):367-73. PubMed ID: 11828012
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hereditary nonpolyposis colorectal cancer families not complying with the Amsterdam criteria show extremely low frequency of mismatch-repair-gene mutations.
    Wijnen J; Khan PM; Vasen H; van der Klift H; Mulder A; van Leeuwen-Cornelisse I; Bakker B; Losekoot M; Møller P; Fodde R
    Am J Hum Genet; 1997 Aug; 61(2):329-35. PubMed ID: 9311737
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Assessment of the in vivo mutagenicity of ethylene oxide in the tissues of B6C3F1 lacI transgenic mice following inhalation exposure.
    Sisk SC; Pluta LJ; Meyer KG; Wong BC; Recio L
    Mutat Res; 1997 Jul; 391(3):153-64. PubMed ID: 9268040
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Microsatellite instability testing in colorectal carcinoma: choice of markers affects sensitivity of detection of mismatch repair-deficient tumors.
    Hatch SB; Lightfoot HM; Garwacki CP; Moore DT; Calvo BF; Woosley JT; Sciarrotta J; Funkhouser WK; Farber RA
    Clin Cancer Res; 2005 Mar; 11(6):2180-7. PubMed ID: 15788665
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC).
    van der Klift H; Wijnen J; Wagner A; Verkuilen P; Tops C; Otway R; Kohonen-Corish M; Vasen H; Oliani C; Barana D; Moller P; Delozier-Blanchet C; Hutter P; Foulkes W; Lynch H; Burn J; Möslein G; Fodde R
    Genes Chromosomes Cancer; 2005 Oct; 44(2):123-38. PubMed ID: 15942939
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Germline and somatic mutation analyses in the DNA mismatch repair gene MLH3: Evidence for somatic mutation in colorectal cancers.
    Lipkin SM; Wang V; Stoler DL; Anderson GR; Kirsch I; Hadley D; Lynch HT; Collins FS
    Hum Mutat; 2001 May; 17(5):389-96. PubMed ID: 11317354
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Mismatch repair deficiency leads to a unique mode of colorectal tumorigenesis characterized by intratumoral heterogeneity.
    Habano W; Sugai T; Nakamura S
    Oncogene; 1998 Mar; 16(10):1259-65. PubMed ID: 9546427
    [TBL] [Abstract][Full Text] [Related]  

  • 80. MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorigenesis.
    Reitmair AH; Cai JC; Bjerknes M; Redston M; Cheng H; Pind MT; Hay K; Mitri A; Bapat BV; Mak TW; Gallinger S
    Cancer Res; 1996 Jul; 56(13):2922-6. PubMed ID: 8674041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.